Glovista Investments’s Novo Nordisk NVO Stock Holding History

Glovista Investments’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-9,476	Closed	-$255K	–	104
2016 Q2	$255K	Buy	+9,476	New	+$260K	0.05%	89

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Glovista Investments's NVO Position: Q3 2016 in Review

Glovista Investments sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 9,476 shares — an estimated $255K sold.

Glovista Investments first reported a position in NVO in Q2 2016 and held it in 1 quarter. The position peaked at $255K in Q2 2016. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

Glovista Investments reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
Glovista Investments sold 9,476 Novo Nordisk shares in Q3 2016, an estimated $255K.
Glovista Investments first reported a position in Novo Nordisk in Q2 2016 and held it in 1 quarter.
Glovista Investments's Novo Nordisk position peaked at $255K in Q2 2016.
511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Glovista Investments's 13F filing for Q3 2016, filed 14 Nov 2016.